<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-143221" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cogan Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salman</surname>
            <given-names>Ethar J.</given-names>
          </name>
          <aff>University of Wasit</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ethar Salman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-143221.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cogan syndrome is a rare multisystem autoimmune disease affecting the ocular and audiovestibular system with unknown pathogenesis. It occurs mainly in young white adults in the third decade of life as they present with interstitial keratitis and hearing loss. The autoimmune hypothesis is proposed due to the detection of different autoantibodies and the association with vasculitis, polyarteritis nodosa, and collagen vascular disease. Diagnosis requires a multidisciplinary approach based on audio-vestibular symptoms, ocular inflammation, and laboratory findings such as nonreactive serological tests for syphilis. This activity highlights the role of the interprofessional team in the management of patients with Conan syndrome.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology and histopathology of Cogan syndrome.</p></list-item><list-item><p>Summarize the clinical evaluation of Cogan syndrome, including the differential diagnoses.</p></list-item><list-item><p>Review the differential diagnoses of Cogan syndrome.</p></list-item><list-item><p>Summarize the appropriate management of Cogan syndrome with prognosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143221&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143221">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-143221.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cogan syndrome is an autoimmune disease characterized by inflammation of the inner ears and the eyes, presenting with vestibulo-auditory dysfunction and interstitial keratitis.<xref ref-type="bibr" rid="article-143221.r1">[1]</xref>&#x000a0;The disease progresses over 3 to 90 days&#x000a0;and usually shows a response to steroid treatment.<xref ref-type="bibr" rid="article-143221.r2">[2]</xref>&#x000a0;</p>
        <p>Humoral and cellular immune responses are the suggested mechanisms. There is expression and upregulation of cytokines like intercellular cell adhesion molecule-1 (ICAM-1) and (IL-)1&#x003b2;.<xref ref-type="bibr" rid="article-143221.r3">[3]</xref>&#x000a0;Originally, Baumgartner and Morgan described the disease in 1934 as non-syphilitic interstitial keratitis with vestibular dysfunction. However,&#x000a0;Dr. David Cogan defined it as a clinical entity in 1945.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref>&#x000a0;</p>
        <p>Cogan&#x000a0;syndrome is a diagnosis of exclusion, and other differentials, including syphilis, have to be ruled out before diagnosing Cogan&#x000a0;syndrome. Other features of Cogan&#x000a0;syndrome include fever, arthralgia, arthritis, headache, and myalgia. Vascular involvement, including aortitis, is an important manifestation of the disease. Cogan&#x000a0;syndrome is treated with corticosteroids and immunomodulatory therapy. Biologics and immunomodulatory therapy are promising therapies to improve the prognosis in such patients.</p>
      </sec>
      <sec id="article-143221.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>At first, Cogan&#x000a0;syndrome was believed to be a result of <italic toggle="yes">Chlamydia psittaci</italic> infection&#x000a0;because of remarkably elevated titers of antibodies to chlamydia trachomatis and the previous infection reported in a few patients.<xref ref-type="bibr" rid="article-143221.r5">[5]</xref>&#x000a0;The role of <italic toggle="yes">Chlamydia</italic> was not established by Vollertsen et al.<xref ref-type="bibr" rid="article-143221.r6">[6]</xref>&#x000a0;</p>
        <p>Further literature on an infectious agent causing it has continued to stay negative, and antibiotic therapy has been unsuccessful.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref>&#x000a0;Garcia Berrocal et al., in 1999, suggested that Cogan syndrome was due to hypersensitivity response to certain infectious agents, probably virus infection that provokes antibody response and cross-immunity with the proteins of the eye, audiovestibular system, and other organs.<xref ref-type="bibr" rid="article-143221.r7">[7]</xref>&#x000a0;</p>
        <p>Presently it is thought that Cogan syndrome is an autoimmune disease. However, no particular biomarker is present in the standard workup of Cogan syndrome.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref></p>
      </sec>
      <sec id="article-143221.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cogan syndrome is a rare disorder, with around 250 cases announced so far.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref>&#x000a0;It occurs mainly in young White race adults in the third decade of life.<xref ref-type="bibr" rid="article-143221.r8">[8]</xref>&#x000a0;The mean age of onset is 25 years, with a range of 5 to 63 years.<xref ref-type="bibr" rid="article-143221.r9">[9]</xref>&#x000a0;No gender&#x000a0;predominance&#x000a0;seemed to occur in the reported cases.<xref ref-type="bibr" rid="article-143221.r10">[10]</xref>&#x000a0;</p>
        <p>It is an exceedingly rare disorder in Middle Eastern countries. However, the first case was reported in Jordan in 2012.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref>&#x000a0;The number of cases could be more than reported as many may be falsely diagnosed as idiopathic keratitis and idiopathic hearing loss or deafness.<xref ref-type="bibr" rid="article-143221.r11">[11]</xref></p>
      </sec>
      <sec id="article-143221.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cogan syndrome is believed to be an autoimmune disease due to the detection of different autoantibodies and associated vasculitis, polyarteritis nodosa, and collagen vascular disease.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref>&#x000a0;Furthermore, the antibodies against the Cogan peptide demonstrated a cross-reaction with Reovirus type III structural protein, proposing the involvement of a virus through a molecular mimicry mechanism. This suggests similarities between foreign and self-peptides resulting in the cross-activation of the cells by the peptides.<xref ref-type="bibr" rid="article-143221.r12">[12]</xref>&#x000a0;</p>
        <p>Molecular mimicry is one of the mechanisms through which autoimmunity can arise. This happens when the exogenous agents such as bacteria, viruses, and others and human normal host-cell components share the antigenic determinants.<xref ref-type="bibr" rid="article-143221.r12">[12]</xref>&#x000a0;However, before the onset of Cogan syndrome, infection with Reovirus type III causing upper respiratory infections, pharyngitis, and mild rhinitis are frequently observed.<xref ref-type="bibr" rid="article-143221.r9">[9]</xref>&#x000a0;</p>
        <p>A study was done in 2002 in which a peptide called Cogan peptide was discovered in 8 patients. The peptide was like reovirus III major core protein lambda and SSA/Ro.<xref ref-type="bibr" rid="article-143221.r12">[12]</xref>&#x000a0;Recently, anti-neutrophil cytoplasmic autoantibodies (ANCA) were discovered in 5 patients, and a few cases showed ANCA-related glomerulonephritis.<xref ref-type="bibr" rid="article-143221.r13">[13]</xref></p>
      </sec>
      <sec id="article-143221.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A histopathologic examination of corneal tissue and cochlea by multiple groups showed plasma cells and lymphocytes infiltration, indicating a cell-mediated reaction that&#x000a0;may explain the audiovestibular dysfunction, which includes severe vertigo, bilateral fluctuating hearing loss, and tinnitus.<xref ref-type="bibr" rid="article-143221.r14">[14]</xref>&#x000a0;</p>
        <p>In addition to cochlear neuron loss, endolymphatic hydrops, new bone formation, degenerative changes in the organ of Corti, and atrophy and demyelination of vestibulocochlear cranial nerve may be noted.<xref ref-type="bibr" rid="article-143221.r15">[15]</xref><xref ref-type="bibr" rid="article-143221.r16">[16]</xref>&#x000a0;</p>
        <p>Further&#x000a0;pathologic findings that are nonspecific yet compatible with a chronic inflammatory process&#x000a0;include damaged aortic valves in aortitis,&#x000a0;aortic valve&#x000a0;cusp detachments and outpouchings, thinning or thickening, fenestrations, and retraction.<xref ref-type="bibr" rid="article-143221.r17">[17]</xref><xref ref-type="bibr" rid="article-143221.r18">[18]</xref>&#x000a0;</p>
        <p>Microscopically, lymphoid cell infiltration, myxomatous changes, and fibrinoid necrosis were revealed in the affected valves.<xref ref-type="bibr" rid="article-143221.r19">[19]</xref><xref ref-type="bibr" rid="article-143221.r20">[20]</xref><xref ref-type="bibr" rid="article-143221.r21">[21]</xref></p>
      </sec>
      <sec id="article-143221.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Haynes and co-authors brought up a classification of Cogan syndrome in 1980 as typical (defined by Cogan) and atypical (structures other than cornea are involved, such as uvea, conjunctiva, sclera, optic disc, and retinal vessels).<xref ref-type="bibr" rid="article-143221.r22">[22]</xref>&#x000a0;Typical or classic Cogan syndrome is characterized by:</p>
        <list list-type="bullet">
          <list-item>
            <p>1- non-syphilitic interstitial keratitis (IK) with possible iritis, subconjunctival/conjunctival hemorrhage, lacrimation, and red-eye. The keratitis begins in the subepithelial region and rapidly evolves into interstitial keratitis that usually develops corneal neovascularization. Interstitial keratitis is the most common ocular feature of Cogan syndrome. One or both eyes can be involved. Usually, the visual prognosis is good. The interstitial keratitis progresses rapidly and then resolves, usually with corneal scarring and ghost vessels. The symptoms of active IK include redness, sensitivity to light (photophobia), visual decline, ocular pain, and watering. There may be recurrences of these symptoms years after initial resolution.</p>
          </list-item>
          <list-item>
            <p>2- vestibular association similar to M&#x000e9;ni&#x000e8;re disease, with gradual hearing loss that might lead to deafness occurring within two years from the eye symptoms.&#x000a0;The&#x000a0;sensorineural hearing loss&#x000a0;usually aggravates rapidly, usually leading to deafness in 1&#x000a0;to 3 months. In typical Cogan syndrome, the vestibulo-auditory symptoms arise within two years of ocular involvement.<xref ref-type="bibr" rid="article-143221.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>In contrast, atypical Cogan syndrome is when</p>
        <list list-type="bullet">
          <list-item>
            <p>1. other types of ocular involvement are present such as conjunctivitis, scleritis, choroiditis, episcleritis, uveitis, closed-angle glaucoma, retinal vasculitis, retinal hemorrhages, retinal artery occlusion, central retinal vein occlusion, exophthalmos, vasculitis optic neuropathy, papillitis, or optic disc edema,</p>
          </list-item>
          <list-item>
            <p>2. audiovestibular symptoms do not resemble M&#x000e9;ni&#x000e8;re disease or appear before or after ocular symptoms for more than two years.<xref ref-type="bibr" rid="article-143221.r7">[7]</xref>&#x000a0;Systemic features are more common in atypical Cogan syndrome.</p>
          </list-item>
        </list>
        <p>However, patients with typical Cogan syndrome may develop features of atypical Cogan syndrome later.<xref ref-type="bibr" rid="article-143221.r23">[23]</xref></p>
        <p>Cogan syndrome follows an upper respiratory tract infection (URTI) episode in almost 27% of reported cases. A history of diarrhea, immunization or dental infections may be present.&#x000a0;Mostly, the ears or the eyes alone are firstly affected. The most common ocular involvement is interstitial keratitis and other presentations: retinal vascular disease, scleritis, uveitis, episcleritis, papilledema, exophthalmos, conjunctivitis, and tendonitis.&#x000a0;Seventy-four percent of patients present with ocular redness, 50% with pain, 50% with photophobia and tearing, and 42% with diminished visual acuity.&#x000a0;</p>
        <p>Examination shows ciliary injection associated with iritis, opacities in the corneal stroma, and a granular corneal infiltration, especially in the posterior portion of the cornea close to the limbus.&#x000a0;Secondary corneal neovascularization usually occurs. Both eyes are involved&#x000a0;in most patients. However, the symptoms may differ&#x000a0;in each eye. Some patients may present with blindness or amaurosis.<xref ref-type="bibr" rid="article-143221.r24">[24]</xref>&#x000a0;</p>
        <p>Multiple&#x000a0;organs are affected in&#x000a0;2/3rd of&#x000a0;cases, and another systemic disorder was seen in 1/3rd of the cases.&#x000a0;Interstitial keratitis may not be the presenting feature and may develop years later.&#x000a0;There may be sectoral conjunctival congestion with subepithelial/anterior corneal stromal peripheral or mid-peripheral keratitis.</p>
        <p>The first system affected is the vestibular system, followed by the cochlear system in days or weeks.&#x000a0;The symptoms are similar to recurrent M&#x000e9;ni&#x000e8;re disease, including nausea, vomiting, vertigo, and tinnitus. Progressive sensory hearing loss is noted that causes deafness in 1-3 months.&#x000a0;Spontaneous nystagmus and a degree of ataxia can occur.&#x000a0;A study by Grasland et al.&#x000a0;showed that&#x000a0;the disease affects both the ocular and audiovestibular system&#x000a0;in 17/52 (33%) patients with typical Cogan syndrome compared to atypical Cogan syndrome (12% of patients).<xref ref-type="bibr" rid="article-143221.r24">[24]</xref>&#x000a0;</p>
        <p>Systemic involvement is present in around 30 to 80% of patients.&#x000a0;Cardiovascular manifestations typically involve aortitis,&#x000a0;which leads to aortic insufficiency in around 10% of patients and congestive heart failure.<xref ref-type="bibr" rid="article-143221.r25">[25]</xref>&#x000a0;</p>
        <p>Neurologic symptoms are nonspecific, including headache and coma.&#x000a0;Some rare manifestations such as pyramidal syndrome, spinal cord disease, cerebellar syndrome, meningeal syndrome, peripheral neuropathy, facial palsy, and encephalitis may occur.<xref ref-type="bibr" rid="article-143221.r24">[24]</xref>&#x000a0;</p>
        <p>Musculoskeletal manifestations may occur, including arthritis, myalgias, synovitis, arthralgia, and articular effusion. Results of muscle biopsies may&#x000a0;be abnormal and show atrophy and muscle necrosis and may mimic myositis.&#x000a0;The rest of the systemic manifestations are quite rare&#x000a0;such as cutaneous signs (urticarial rash, erythematous rash, nodules, ulcerations, vascular purpura), lung involvement (dyspnea, cough, pleurisy, hemoptysis, thoracic pain, discrete&#x000a0;abnormalities on radiological images), urinalysis abnormalities, and lymphadenopathies.<xref ref-type="bibr" rid="article-143221.r26">[26]</xref></p>
      </sec>
      <sec id="article-143221.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Unfortunately, there is no particular marker for Cogan syndrome. However, some&#x000a0;labs can be abnormal. Differential diagnoses must be ruled out by extensive investigations as Cogan syndrome is a diagnosis of exclusion. The usual findings are anemia, leukocytosis, thrombocytosis, and elevated ESR (erythrocyte sedimentation rate) along with hypofibrinogenemia and high CRP (c-reactive protein) during acute attacks.&#x000a0;In some cases, antibodies against <italic toggle="yes">Chlamydia&#x000a0;trachomatis</italic> or <italic toggle="yes">Chlamydia psittaci</italic> may be discovered. However,&#x000a0;other features of&#x000a0;infections may be absent.<xref ref-type="bibr" rid="article-143221.r24">[24]</xref>&#x000a0;</p>
        <p>On urinalysis, proteinuria and hematuria&#x000a0;may be present. Certain antibodies&#x000a0;may be present, including antinuclear antibodies (ANA), antibodies to smooth muscle, lupus anticoagulants, cryoglobulins, anti-neutrophil cytoplasmic autoantibodies (ANCA), or rheumatoid factor (RF). In some cases, direct antibodies were detected against components of the inner ear and corneal antigen.<xref ref-type="bibr" rid="article-143221.r24">[24]</xref>&#x000a0;</p>
        <p>Antibodies against heat shock protein may be present in around half of the patients with Cogan syndrome. Audiometry shows sensorineural hearing loss of all frequencies.&#x000a0;Word recognition ability might improve or deteriorate; the initial evaluation demonstrates sensory hearing loss with abnormal electronystagmography.<xref ref-type="bibr" rid="article-143221.r27">[27]</xref></p>
      </sec>
      <sec id="article-143221.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of Cogan syndrome depends on its severity, whether it&#x000a0;is limited to ocular disease or extensive inner ear, ocular or systemic vasculitis. High-dose corticosteroids (1&#x000a0;to 2 mg/kg/day) for systemic vasculitis are the first line to obtain remission.<xref ref-type="bibr" rid="article-143221.r28">[28]</xref></p>
        <p>If an improvement occurs, corticosteroids&#x000a0;may be tapered over 2&#x000a0;to 6 months. The corticosteroid should be discontinued if no response occurs.&#x000a0;Failure of treatment will require additional immunosuppressive therapy like methotrexate, azathioprine, cyclophosphamide, and cyclosporine A, which have shown better outcomes.<xref ref-type="bibr" rid="article-143221.r29">[29]</xref><xref ref-type="bibr" rid="article-143221.r30">[30]</xref>&#x000a0;</p>
        <p>Interstitial keratitis is treated with topical steroids and cycloplegics, systemic steroids,&#x000a0;disease-modifying anti-rheumatic drugs (DMARDs), and biologics.</p>
        <p>The early treatment with systemic corticosteroids determines the course of audiovestibular involvement. However, corticosteroid eye drops or local atropine can be used for interstitial keratitis, which shows a good response. Cogan syndrome with large vessel vasculitis&#x000a0;has also been treated with oral cyclophosphamide (starting at 2 to 3 mg/kg/day)&#x000a0;given for four to six months.&#x000a0;If no response to cyclophosphamide is noted, cyclosporine (4 mg/kg/day or less) may be used.<xref ref-type="bibr" rid="article-143221.r30">[30]</xref></p>
        <p>Tumor necrosis factors (TNF-a) inhibitory agents have recently been another therapeutic option, with infliximab, a chimeric anti-TNF-a monoclonal antibody being the most effective, according to a recent literature review that showed 11 out of 12 cases treated with infliximab have achieved clinical remission.<xref ref-type="bibr" rid="article-143221.r31">[31]</xref><xref ref-type="bibr" rid="article-143221.r32">[32]</xref>&#x000a0;</p>
        <p>Rituximab has been shown to&#x000a0;reduce the medications used to control the systemic manifestations and help avoid cochlear implants or deafness in certain severe cases; however, it is not used as a first-line.<xref ref-type="bibr" rid="article-143221.r33">[33]</xref>&#x000a0;For those who did not respond to pharmacologic therapy for hearing loss, cochlear implants have been beneficial.<xref ref-type="bibr" rid="article-143221.r34">[34]</xref><xref ref-type="bibr" rid="article-143221.r35">[35]</xref>&#x000a0;</p>
        <p>Benzodiazepines, antihistamines, or vestibular therapy can be used for chronic vestibular dysfunction that occurs in a few cases.<xref ref-type="bibr" rid="article-143221.r36">[36]</xref>&#x000a0;A fast-growing interest in stem-cell-based treatment has developed for autoimmune disorders; however, additional studies are required to&#x000a0;confirm the long-term safety and efficacy.<xref ref-type="bibr" rid="article-143221.r37">[37]</xref></p>
      </sec>
      <sec id="article-143221.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Various diseases have been included in the differential diagnosis of Cogan syndrome due to the audiovestibular and ocular associations such as these:</p>
        <list list-type="bullet">
          <list-item>
            <p>Susac syndrome (retinocochleocerberal vasculopathy or SICRET syndrome-small infarctions of cochlear, retinal, and encephalic tissue):&#x000a0;Susac syndrome is characterized by lesions of the cochlear, retinal, and cerebral arterioles.<xref ref-type="bibr" rid="article-143221.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Congenital syphilis: The Hutchinson triad of congenital syphilis includes Hutchinson teeth (notched peg-shaped upper incisors), interstitial keratitis, and sensorineural hearing loss.<xref ref-type="bibr" rid="article-143221.r38">[38]</xref>&#x000a0;Serology for syphilis&#x000a0;must be negative for making a diagnosis of Cogan syndrome.</p>
          </list-item>
          <list-item>
            <p>The association of necrotizing vasculitis after acute serous otitis media and acute episcleritis described&#x000a0;by Sergent and Christian in 1994 (with no inner ear involvement)</p>
          </list-item>
          <list-item>
            <p>Vogt-Koyanagi-Harada syndrome:&#x000a0;Vogt-Koyanagi-Harada syndrome is identified by diminished visual acuity, sensorineural hearing loss, and uveoencephalitis with meningism (which sometimes occurs in Cogan syndrome), poliosis, and alopecia.&#x000a0;Meningism may occur in patients with Cogan syndrome. However, alopecia and poliosis do not.<xref ref-type="bibr" rid="article-143221.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Polyarteritis nodosa</p>
          </list-item>
          <list-item>
            <p>Granulomatosis with polyangiitis: Granulomatosis with polyangiitis often involves the ear and eye. Vasculitic changes involving small vessels, pulmonary infiltrates, glomerulonephritis, hemorrhagic lesions of the nose and throat, and the presence of c-ANCA (cytoplasmic ANCA) are usually seen in patients with granulomatosis with polyangiitis (previously called Wegner granulomatosis). Cogan syndrome patients do not fulfill these criteria.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Takayasu arteritis<xref ref-type="bibr" rid="article-143221.r11">[11]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>It is challenging to diagnose Cogan syndrome during the early stages of the disease.&#x000a0;However, the coexistence between Cogan syndrome and other autoimmune disorders has been revealed by a literature review, such as the presence of Cogan syndrome with rheumatoid arthritis,&#x000a0;granulomatosis with polyangiitis,&#x000a0;and tubulointerstitial nephritis, and uveitis (TINU syndrome).<xref ref-type="bibr" rid="article-143221.r39">[39]</xref>&#x000a0;</p>
        <p>A study showed that four patients with inflammatory bowel disease (IBD) presented with Cogan syndrome, ocular inflammation, and sensorineural hearing loss (SNHL) after the GI (gastrointestinal) symptoms.<xref ref-type="bibr" rid="article-143221.r40">[40]</xref>&#x000a0;A large international multicenter study reported 22 CS-IBD patients; half of them had Cogan syndrome onset after the GI symptoms.<xref ref-type="bibr" rid="article-143221.r41">[41]</xref></p>
        <p>Differential diagnoses of interstitial keratitis include&#x000a0;syphilis, chlamydia, leprosy, tuberculosis, brucellosis, leptospirosis, Lyme disease, herpes, measles, mumps, pox, parasitic infestation (onchocerciasis),&#x000a0;and autoimmune diseases (rheumatoid arthritis, sarcoidosis, granulomatosis with polyangiitis).<xref ref-type="bibr" rid="article-143221.r42">[42]</xref></p>
      </sec>
      <sec id="article-143221.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for Cogan syndrome is generally poor when ear, eye, and cardiovascular involvement occur. In contrast to corneal disease, ear disease has a poor prognosis in the long term as deafness will be irreversible.<xref ref-type="bibr" rid="article-143221.r26">[26]</xref>&#x000a0;</p>
        <p>Complete hearing loss was noted in one ear in 18 percent and both ears in 52 percent of 60 patients who received care at Mayo clinic between 1940&#x000a0;and 2002. At the final follow-up, most patients had normal or near-normal eyesight in this study.&#x000a0;A&#x000a0;retrospective study&#x000a0;on Cogan syndrome from France showed higher relapse rates from patients at Mayo clinic (78% during 7.1 years of follow-up) than relapse rates (13 and 31 percent of patients relapsed at 5 and 10 years, respectively).<xref ref-type="bibr" rid="article-143221.r43">[43]</xref>&#x000a0;</p>
        <p>Both groups were uniformly treated with high doses of glucocorticoids.&#x000a0;However, the patients from the French study had&#x000a0;more use of immunosuppressive agents than those managed at the Mayo Clinic. In the French study, ten patients were treated with infliximab which was only approved in late 1998.&#x000a0;Deterioration of auditory performance after cochlear implants have been noticed by Bovo et al. due to the progression of new bone in the cochlea, which separates the electrode from neural structures.<xref ref-type="bibr" rid="article-143221.r44">[44]</xref><xref ref-type="bibr" rid="article-143221.r45">[45]</xref></p>
      </sec>
      <sec id="article-143221.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Systemic vasculitis, usually involving large and/or medium vessels, has been reported in 15&#x000a0;to 21% of cases. However, vessels of any size may be affected.<xref ref-type="bibr" rid="article-143221.r46">[46]</xref>&#x000a0;Life-threatening complications were reported in 10% of cases like aortic insufficiency, aneurysms, and dissection.<xref ref-type="bibr" rid="article-143221.r47">[47]</xref>&#x000a0;Other valves were involved&#x000a0;leading to complications including&#x000a0;mitral insufficiency.<xref ref-type="bibr" rid="article-143221.r48">[48]</xref></p>
        <p>Organs that may be affected by systemic vasculitis&#x000a0;include the brain and kidneys, as the stroke was seen in some Cogan syndrome patients.<xref ref-type="bibr" rid="article-143221.r49">[49]</xref>&#x000a0;Neurological symptoms include aphasia due to TIA (transient ischemic attack), hemiplegia, and hemiparesis&#x000a0;due to a cerebral vascular accident.</p>
      </sec>
      <sec id="article-143221.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Cogan syndrome is a rare autoimmune disorder that presents with audiovestibular symptoms and non-syphilitic interstitial keratitis. The beneficial response to corticosteroids supports autoimmune pathogenesis. However, the treatment is sometimes difficult as failure to treat hearing loss may cause deafness. Permanent hearing loss usually occurs due to recurrent flares.<xref ref-type="bibr" rid="article-143221.r50">[50]</xref>&#x000a0;</p>
        <p>The first line of treatment is corticosteroids. Additionally, multiple immunosuppressive drugs have been used.<xref ref-type="bibr" rid="article-143221.r50">[50]</xref>&#x000a0;Cochlear implantation is a surgical strategy used in cases with severe sensorineural hearing loss and failure of intensive immunosuppressive regimens.<xref ref-type="bibr" rid="article-143221.r50">[50]</xref>&#x000a0;</p>
        <p>The patients and caregivers should be explained the prognosis, management, and outcome to ensure compliance and the best possible outcome.</p>
      </sec>
      <sec id="article-143221.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The collaboration of the entire healthcare team is mandatory for the management of this condition. The primary care providers should be oriented about this disorder, especially if they present with progressive hearing loss and eye pain. A referral to an ophthalmologist and otolaryngologist for further assessment is mandatory. Screening for other autoimmune diseases should be considered to improve prognosis and outcomes.</p>
      </sec>
      <sec id="article-143221.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143221&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143221">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/cogan-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=143221">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/143221/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=143221">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-143221.s16">
        <fig id="article-143221.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Slit-lamp image shows interstitial keratitis in a patient with hearing loss. Cogan syndrome was suspected as the serology for syphilis was negative Contributed by Dr. Prabhakar Singh, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="20190119_130413_OD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-143221.s17">
        <title>References</title>
        <ref id="article-143221.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kessel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vadasz</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Toubi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cogan syndrome--pathogenesis, clinical variants and treatment approaches.</article-title>
            <source>Autoimmun Rev</source>
            <year>2014</year>
            <season>Apr-May</season>
            <volume>13</volume>
            <issue>4-5</issue>
            <fpage>351</fpage>
            <page-range>351-4</page-range>
            <pub-id pub-id-type="pmid">24418297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCabe</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune sensorineural hearing loss.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>1979</year>
            <season>Sep-Oct</season>
            <volume>88</volume>
            <issue>5 Pt 1</issue>
            <fpage>585</fpage>
            <page-range>585-9</page-range>
            <pub-id pub-id-type="pmid">496191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodall</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Siddiq</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Current understanding of the pathogenesis of autoimmune inner ear disease: a review.</article-title>
            <source>Clin Otolaryngol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>412</fpage>
            <page-range>412-9</page-range>
            <pub-id pub-id-type="pmid">25847404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iliescu</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Timaru</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Batras</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Simone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stefan</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>COGAN'S SYNDROME.</article-title>
            <source>Rom J Ophthalmol</source>
            <year>2015</year>
            <season>Jan-Mar</season>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-13</page-range>
            <pub-id pub-id-type="pmid">27373108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Kaiser-Kupfer</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fauci</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>59</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-41</page-range>
            <pub-id pub-id-type="pmid">6969345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vollertsen</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Vasculitis and Cogan's syndrome.</article-title>
            <source>Rheum Dis Clin North Am</source>
            <year>1990</year>
            <month>May</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>433</fpage>
            <page-range>433-9</page-range>
            <pub-id pub-id-type="pmid">2189159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a Berrocal</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Vaquero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ram&#x000f3;n y Cajal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez-Camacho</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: an oculo-audiovestibular disease.</article-title>
            <source>Postgrad Med J</source>
            <year>1999</year>
            <month>May</month>
            <volume>75</volume>
            <issue>883</issue>
            <fpage>262</fpage>
            <page-range>262-4</page-range>
            <pub-id pub-id-type="pmid">10533627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tayer-Shifman</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Ilan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tovi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tal</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome--clinical guidelines and novel therapeutic approaches.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-72</page-range>
            <pub-id pub-id-type="pmid">24385257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vollertsen</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Younge</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Stanson</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Ilstrup</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: 18 cases and a review of the literature.</article-title>
            <source>Mayo Clin Proc</source>
            <year>1986</year>
            <month>May</month>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>344</fpage>
            <page-range>344-61</page-range>
            <pub-id pub-id-type="pmid">3486332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azami</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maleki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kalantar Hormozi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tavosi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Interstitial Keratitis, Vertigo, and Vasculitis: Typical Cogan's Syndrome.</article-title>
            <source>Case Rep Med</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>830831</fpage>
            <pub-id pub-id-type="pmid">24715922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaubitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>L&#x000fc;bben</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Seidel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schotte</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gramley</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Domschke</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: organ-specific autoimmune disease or systemic vasculitis? A report of two cases and review of the literature.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2001</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-9</page-range>
            <pub-id pub-id-type="pmid">11491507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lunardi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bason</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leandri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Navone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lestani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Millo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Benatti</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Cilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corrocher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Puccetti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Sep</month>
            <day>21</day>
            <volume>360</volume>
            <issue>9337</issue>
            <fpage>915</fpage>
            <page-range>915-21</page-range>
            <pub-id pub-id-type="pmid">12354474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamanishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ishioka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maeda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamakido</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Letter to the Editor. Atypical Cogan's syndrome associated with antineutrophil cytoplasmic autoantibodies.</article-title>
            <source>Br J Rheumatol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-2</page-range>
            <pub-id pub-id-type="pmid">8670587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FISHER</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>HELLSTROM</surname>
                <given-names>HR</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome and systemic vascular disease. Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger).</article-title>
            <source>Arch Pathol</source>
            <year>1961</year>
            <month>Nov</month>
            <volume>72</volume>
            <fpage>572</fpage>
            <page-range>572-92</page-range>
            <pub-id pub-id-type="pmid">13893233</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rarey</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Bicknell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Intralabyrinthine osteogenesis in Cogan's syndrome.</article-title>
            <source>Am J Otolaryngol</source>
            <year>1986</year>
            <season>Nov-Dec</season>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>387</fpage>
            <page-range>387-90</page-range>
            <pub-id pub-id-type="pmid">3099589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schuknecht</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Nadol</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Temporal bone pathology in a case of Cogan's syndrome.</article-title>
            <source>Laryngoscope</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>104</volume>
            <issue>9</issue>
            <fpage>1135</fpage>
            <page-range>1135-42</page-range>
            <pub-id pub-id-type="pmid">8072362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cochrane</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Tatoulis</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>1166</fpage>
            <page-range>1166-7</page-range>
            <pub-id pub-id-type="pmid">1953144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Livingston</surname>
                <given-names>JZ</given-names>
              </name>
              <name>
                <surname>Casale</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hutchins</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Coronary involvement in Cogan's syndrome.</article-title>
            <source>Am Heart J</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>123</volume>
            <issue>2</issue>
            <fpage>528</fpage>
            <page-range>528-30</page-range>
            <pub-id pub-id-type="pmid">1736593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gelfand</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Kantor</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gorstein</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome with cardiovascular involvement: aortic insufficiency.</article-title>
            <source>Bull N Y Acad Med</source>
            <year>1972</year>
            <month>May</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>647</fpage>
            <page-range>647-60</page-range>
            <pub-id pub-id-type="pmid">4503925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>EISENSTEIN</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>TAUBENHAUS</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nonsyphilitic interstitial keratitis and bilateral deafness (Cogan's syndrome) associated with cardiovascular disease.</article-title>
            <source>N Engl J Med</source>
            <year>1958</year>
            <month>May</month>
            <day>29</day>
            <volume>258</volume>
            <issue>22</issue>
            <fpage>1074</fpage>
            <page-range>1074-9</page-range>
            <pub-id pub-id-type="pmid">13552923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinals</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome with arthritis and aortic insufficiency.</article-title>
            <source>J Rheumatol</source>
            <year>1978</year>
            <season>Fall</season>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>294</fpage>
            <page-range>294-8</page-range>
            <pub-id pub-id-type="pmid">748553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonaguri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Orsoni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bacciu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lippi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melegari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zavota</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ghirardini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: anti-Hsp70 antibodies are a serological marker in the typical form.</article-title>
            <source>Isr Med Assoc J</source>
            <year>2014</year>
            <month>May</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>285</fpage>
            <page-range>285-8</page-range>
            <pub-id pub-id-type="pmid">24979832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Espinoza</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Temprano</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Cogan's Syndrome: Clinical Presentations and Update on Treatment.</article-title>
            <source>Curr Allergy Asthma Rep</source>
            <year>2020</year>
            <month>Jun</month>
            <day>16</day>
            <volume>20</volume>
            <issue>9</issue>
            <fpage>46</fpage>
            <pub-id pub-id-type="pmid">32548646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grasland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pouchot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bl&#x000e9;try</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Papo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vinceneux</surname>
                <given-names>P</given-names>
              </name>
              <collab>Study Group for Cogan's Syndrome</collab>
            </person-group>
            <article-title>Typical and atypical Cogan's syndrome: 32 cases and review of the literature.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>1007</fpage>
            <page-range>1007-15</page-range>
            <pub-id pub-id-type="pmid">15150435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erkanl&#x00131;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x00131;l&#x00131;n&#x000e7;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bak&#x00131;r</surname>
                <given-names>&#x00130;</given-names>
              </name>
            </person-group>
            <article-title>Surgical Treatment in a Case of Cogan's Syndrome Complicated With Proximal Aortic Vasculitis.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>100</volume>
            <issue>4</issue>
            <fpage>1467</fpage>
            <page-range>1467-9</page-range>
            <pub-id pub-id-type="pmid">26434452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ndiaye</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Rassi</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Wiener-Vacher</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Cochleovestibular impairment in pediatric Cogan's syndrome.</article-title>
            <source>Pediatrics</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>109</volume>
            <issue>2</issue>
            <fpage>E38</fpage>
            <pub-id pub-id-type="pmid">11826248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Osborne</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: auditory and medical management.</article-title>
            <source>J Am Acad Audiol</source>
            <year>1992</year>
            <month>May</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-9</page-range>
            <pub-id pub-id-type="pmid">1581598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shamriz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tal</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.</article-title>
            <source>J Immunol Res</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>1498640</fpage>
            <pub-id pub-id-type="pmid">29850616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matteson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Tirzaman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Facer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Fabry</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kasperbauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beatty</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Use of methotrexate for autoimmune hearing loss.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>109</volume>
            <issue>8 Pt 1</issue>
            <fpage>710</fpage>
            <page-range>710-4</page-range>
            <pub-id pub-id-type="pmid">10961801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Cobo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kisslo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>McCallum</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>BF</given-names>
              </name>
            </person-group>
            <article-title>Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome.</article-title>
            <source>Am J Med</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>296</fpage>
            <page-range>296-301</page-range>
            <pub-id pub-id-type="pmid">2309745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Touma</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Nawwar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hadi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hourani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arayssi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The use of TNF-alpha blockers in Cogan's syndrome.</article-title>
            <source>Rheumatol Int</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>995</fpage>
            <page-range>995-6</page-range>
            <pub-id pub-id-type="pmid">17564714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalogeropoulos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Karachalios</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pentheroudakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tsikou-Papafrangou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abou-Asabeh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Argyropoulou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drosos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pavlidis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Development of a low grade lymphoma in the mastoid bone in a patient with atypical Cogan's syndrome: A case report.</article-title>
            <source>J Adv Res</source>
            <year>2015</year>
            <month>May</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>523</fpage>
            <page-range>523-7</page-range>
            <pub-id pub-id-type="pmid">26257951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orsoni</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Lagan&#x000e0;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rubino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zavota</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bacciu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2010</year>
            <month>Jun</month>
            <day>16</day>
            <volume>5</volume>
            <fpage>18</fpage>
            <pub-id pub-id-type="pmid">20550723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peters</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Wyss</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manrique</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Worldwide trends in bilateral cochlear implantation.</article-title>
            <source>Laryngoscope</source>
            <year>2010</year>
            <month>May</month>
            <volume>120 Suppl 2</volume>
            <fpage>S17</fpage>
            <page-range>S17-44</page-range>
            <pub-id pub-id-type="pmid">20422715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Shipp</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nedzelski</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Cochlear implantation in patients with autoimmune inner ear disease including cogan syndrome: a comparison with age- and sex-matched controls.</article-title>
            <source>Laryngoscope</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>120</volume>
            <issue>12</issue>
            <fpage>2478</fpage>
            <page-range>2478-83</page-range>
            <pub-id pub-id-type="pmid">21082747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coelho</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lalwani</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Medical management of M&#x000e9;ni&#x000e8;re's disease.</article-title>
            <source>Laryngoscope</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>118</volume>
            <issue>6</issue>
            <fpage>1099</fpage>
            <page-range>1099-108</page-range>
            <pub-id pub-id-type="pmid">18418279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ben-Ami</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berrih-Aknin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.</article-title>
            <source>Autoimmun Rev</source>
            <year>2011</year>
            <month>May</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>410</fpage>
            <page-range>410-5</page-range>
            <pub-id pub-id-type="pmid">21256250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vohra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Triads in Ophthalmology: A Comprehensive Review.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2017</year>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-250</page-range>
            <pub-id pub-id-type="pmid">26148300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brogan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eleftheriou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rajput</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Edelsten</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sebire</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Brogan</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan's overlap syndrome.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2012</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>950</fpage>
            <page-range>950-2</page-range>
            <pub-id pub-id-type="pmid">22240503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scharl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Frei</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fried</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vavricka</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Association between Cogan's syndrome and inflammatory bowel disease: a case series.</article-title>
            <source>J Crohns Colitis</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-8</page-range>
            <pub-id pub-id-type="pmid">21272808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vavricka</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Greuter</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scharl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mantzaris</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shitrit</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Filip</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Karmiris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thoeringer</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Boldys</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wewer</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Yanai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Flores</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kariv</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rogler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rahier</surname>
                <given-names>JF</given-names>
              </name>
              <collab>ECCO CONFER investigators</collab>
            </person-group>
            <article-title>Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case Series.</article-title>
            <source>J Crohns Colitis</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>886</fpage>
            <page-range>886-90</page-range>
            <pub-id pub-id-type="pmid">26188351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r42">
          <label>42</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gyasi</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Okonkwo</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Onchocerciasis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Durtette</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Resche-Rigon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Papo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Z&#x000e9;none</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lioger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deligny</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Landron</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pouchot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lavigne</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Wazieres</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dhote</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gondran</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pertuiset</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Quemeneur</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hamidou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ve</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Gallou</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grasland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hatron</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Fain</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mekinian</surname>
                <given-names>A</given-names>
              </name>
              <collab>SNFMI and CRI</collab>
            </person-group>
            <article-title>Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature review.</article-title>
            <source>Autoimmun Rev</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>1219</fpage>
            <page-range>1219-1223</page-range>
            <pub-id pub-id-type="pmid">29037902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasanisi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vincenti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bacciu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berghenti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barbot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orsoni</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Bacciu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cochlear implantation and Cogan syndrome.</article-title>
            <source>Otol Neurotol</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>601</fpage>
            <page-range>601-4</page-range>
            <pub-id pub-id-type="pmid">12851552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kashio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kakigi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamasoba</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cochlear implantation in a patient with atypical Cogan's syndrome complicated with hypertrophic cranial pachymeningitis.</article-title>
            <source>Auris Nasus Larynx</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-41</page-range>
            <pub-id pub-id-type="pmid">20576375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fusconi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Magliulo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Turchetta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marinelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Macri</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>De Virgilio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Vincentiis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome: an autoimmune inner ear disease.</article-title>
            <source>Autoimmun Rev</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>396</fpage>
            <page-range>396-400</page-range>
            <pub-id pub-id-type="pmid">22846458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Tay</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Sebastian</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Thumboo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sin</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Recurrent aortic aneurysms following thoracic aortic stent-graft repair in a patient with Cogan syndrome.</article-title>
            <source>J Endovasc Ther</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>779</fpage>
            <page-range>779-82</page-range>
            <pub-id pub-id-type="pmid">17154705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasparovic</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Djuric</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bosnic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Petricevic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dotlic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biocina</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Aortic root vasculitis associated with Cogan's syndrome.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>92</volume>
            <issue>1</issue>
            <fpage>340</fpage>
            <page-range>340-1</page-range>
            <pub-id pub-id-type="pmid">21718871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blatt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Goldhammer</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Cogan's syndrome complicated by lacunar brain infarcts.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>169</fpage>
            <page-range>169-71</page-range>
            <pub-id pub-id-type="pmid">2019845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143221.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Aguanno</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ralli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Vincentiis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Optimal management of Cogan's syndrome: a multidisciplinary approach.</article-title>
            <source>J Multidiscip Healthc</source>
            <year>2018</year>
            <volume>11</volume>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">29317827</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
